Medicina
Departamento
Paul Sabatier University
Tolosa, FranciaPublicaciones en colaboración con investigadores/as de Paul Sabatier University (10)
2023
-
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation
Leukemia, Vol. 37, Núm. 7, pp. 1521-1529
-
Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome
Transplantation, Vol. 107, Núm. 6, pp. 1330-1340
-
Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group
European heart journal, Vol. 44, Núm. 41, pp. 4340-4356
2022
2021
-
Dpyd exome, mrna expression and uracil levels in early severe toxicity to fluoropyrimidines: An extreme phenotype approach
Journal of Personalized Medicine, Vol. 11, Núm. 8
2018
-
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop
Multiple Sclerosis Journal, Vol. 24, Núm. 5, pp. 590-603
-
Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene
Cancer Management and Research, Vol. 10, pp. 4517-4522
2017
-
Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer—GEnetic- and tumor-related biomarkers for response and toxicity
Urologic Oncology: Seminars and Original Investigations, Vol. 35, Núm. 8, pp. 529.e9-529.e16
2014
-
Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinoma
European Journal of Cancer, Vol. 50, Núm. 3, pp. 496-505